BSC
RIGL icon

BOLTON SECURITIES CORPORATION’s Rigel Pharmaceuticals RIGL Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$83.8K Sell
1,740
-4
-0.2% -$174 ﹤0.01% 1178
2026
Q2 		$68.2K Sell
1,744
-4
-0.2% -$123 ﹤0.01% 1232
2026
Q1 		$47.3K Buy
+1,748
New +$58.7K ﹤0.01% 1241

Other funds holding RIGL

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
O'Shaughnessy Asset Management
O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's RIGL Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION reduced its Rigel Pharmaceuticals (RIGL) stake by 0.23% in Q3 2026, selling an estimated $174 and leaving 1,740 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

BOLTON SECURITIES CORPORATION first reported a position in RIGL in Q1 2026 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 1,740 shares of Rigel Pharmaceuticals worth $83.8K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION sold 4 Rigel Pharmaceuticals shares in Q3 2026, an estimated $174.
  • Rigel Pharmaceuticals made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #1178 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.